Opioids modulate post-ischemic progression in a rat model of stroke

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1256-1265

  Kao, Tsung Kuei ^a   Ou, Yen Chuan ^b   Liao, Su Lan ^b,c   Chen, Wen Ying ^c   Wang, Chun Chiang ^b   Chen, Shih Yun ^b   Chiang, An Na ^d   Chen, Chun Jung ^b,c,e  

^a TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Ischemia; Neuroinflammation: Neuroprotection; Opioid; Stroke

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; CYTOKINE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DYNORPHIN[1-13]; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR AGONIST; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; TAPP PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; ENCEPHALITIS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STROKE;

AMIDINES; ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; BRAIN; BRAIN ISCHEMIA; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DYNORPHINS; ENCEPHALITIS; IMMUNE TOLERANCE; INTERLEUKIN-6; MALE; NARCOTIC ANTAGONISTS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; STROKE;

RATTUS;

EID: 40949160522     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.01.007     Document Type: Article

References (50)

1. Araki T., Murakami F., Kanai Y., Kato H., and Kogure K. Naloxone receptor binding in gerbil striatum and hippocampus following transient cerebral ischemia. Neurochem. Int. 23 (1993) 319-325
2. Benfenati F., Pich E.M., Zoli M., Grimaldi R., Fuxe K., and Agnati L.F. Changes in striatal μ and δ opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study. Brain Res. 546 (1991) 171-175
3. Borlongan C.V., Wang Y., and Su T.P. Delta opioid peptide (D-Ala 2 D-Leu 5) enkephalinL linking hibernation and neuroprotection. Front. Biosci. 9 (2004) 3392-3398
4. Boutin H., Catherine A., MacKenzie E.T., Jauzac P., and Dauphin F. Long-term alterations in μ, δ and κ opioidergic receptors following middle cerebral artery occlusion in mice. Acta Neuropathol. 114 (2007) 491-500
5. Boutin H., Dauphin F., MacKenzie E.T., and Jauzac P. Differential time-course decreases in nonselective, μ-, δ-, and κ-opioid receptors after focal cerebral ischemia in mice. Stroke 30 (1999) 1271-1277
6. 3H](+)-BW373U86 to delta-opioid receptors in rat brain membranes. Eur. J. Pharmacol. 310 (1996) 263-267
7. Chang K.J., Rigdon G.C., Howard J.L., and McNutt R.W. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J. Pharmacol. Exp. Ther. 267 (1993) 852-857
8. Chen C.J., Cheng F.C., Liao S.L., Chen W.Y., Lin N.N., and Kuo J.S. Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci. Lett. 287 (2000) 113-116
9. Chen C.J., Liao S.L., Chen W.Y., Hong J.S., and Kuo J.S. Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone. Neuroreport 12 (2001) 1245-1249
10. Chen C.J., Ou Y.C., Lin S.Y., Liao S.L., Chen S.Y., and Chen J.H. Manganese modulates pro-inflammatory gene expression in activated glia. Neurochem. Int. 49 (2006) 62-71
11. Chen Z.C., Kuo J.R., Huang Y.P., and Lin M.T. μ-Opioid receptor blockade protects against circulatory shock and cerebral ischemia during heatstroke. J. Cardiovasc. Pharmacol. 46 (2005) 754-760
12. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23 (1992) 1261-1276
13. Davis R.L., Buck D.J., Saffarian N., and Stevens C.W. The opioid antagonist, β-funaltrexamine, inhibits chemokine expression in human astroglial cells. J. Neuroimmunol. 186 (2007) 141-149
14. 2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50 (2005) 91-106
15. Fallis R.J., Fisher M., and Lobo R.A. A double blind trial of naloxone in the treatment of acute stroke. Stroke 15 (1984) 627-629
16. Guéniau C., and Oberlander C. The kappa opioid agonist Niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J. Pharmacol. Exp. Ther. 282 (1997) 1-6
17. Gutkowska J., and Schiller P.W. Renal effects of TAPP, a highly selective mu-opioid agonist. Br. J. Pharmacol. 119 (1996) 239-244
18. Hsueh C.M., Kuo J.S., and Chen S.F. Ischemia/reperfusion-induced changes of hypothalamic-pituitary-adrenal (HPA) activity is opioid related in Sprague-Dawley rat. Neurosci. Lett. 349 (2003) 155-158
19. Huang P., Chen C., Xu W., Yoon S.I., Unterwald E.M., Pintar J.E., Wang Y., Chong P.L.G., and Liu-Chen L.Y. Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Biochem. Biophys. Res. Commun. 365 (2008) 82-88
20. Iwata M., Inoue S., Kawaguchi M., Nakamura M., Konishi N., and Furuya H. Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischemia. Br. J. Anaesth. 99 (2007) 538-546
21. Jabaily J., and Davis J.N. Naloxone administration to patients with acute stroke. Stroke 15 (1984) 36-39
22. Kao T.K., Ou Y.C., Kuo J.S., Chen W.Y., Liao S.L., Wu C.W., Chen C.J., Ling N.N., Zhang Y.H., and Peng W.H. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem. Int. 48 (2006) 166-176
23. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15 (1995) 615-635
24. Kim J.S., and Lemasters J.J. Opioid receptor-independent protection of ischemic rat hepatocytes by morphine. Biochem. Biophys. Res. Commun. 351 (2006) 958-964
25. Kitagawa K., Matsumoto M., Niinobe M., Mikoshiba K., Hata R., Ueda H., Handa N., Fukunaga R., Isaka Y., and Kimura K. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage-immunohistochemical investigation of dendritic damage. Neuroscience 31 (1989) 401-411
26. Kong L.Y., McMillian M.K., Hudson P.M., Jin L., and Hong J.S. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J. Pharmacol. Exp. Ther. 280 (1997) 61-66
27. Lee J., Kim M.S., Park C., Jung E.B., Choi D.H., Kim T.Y., Moon S.K., and Park R. Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol. Immunotoxicol. 26 (2004) 17-28
28. Liao S.L., Chen W.Y., Raung S.L., and Chen C.J. Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism. Neurosci. Lett. 345 (2003) 169-172
29. Liu B., and Hong J.S. Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors. Methods Mol. Med. 79 (2003) 43-54
30. Liu B., Du L., and Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 293 (2000) 607-617
31. Liu Y., Qin L., Wilson B.C., An L., Hong J.S., and Liu B. Inhibition by naloxone stereoisomers of β-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J. Pharmacol. Exp. Ther. 302 (2002) 1212-1219
32. Miller L., and Perry D.C. Opiate receptor subtype binding in gerbil hippocampus is altered by forebrain ischemia. Brain Res. 495 (1989) 367-372
33. Patel H.H., Hsu A., Moore J., and Gross G.J. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J. Mol. Cell. Cardiol. 33 (2001) 1455-1465
34. Pfefferkorn T., and Rosenberg G.A. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34 (2003) 2025-2030
35. Roy S., and Loh H. Effects of opioids on the immune system. Neurochem. Res. 21 (1996) 1375-1386
36. Ruzicka B.B., Fox C.A., Thompson R.C., Meng F., Watson S.J., and Akil H. Primary astroglial cultures derived from several rat brain regions differentially express mu, delta, and kappa opioid receptor mRNA. Brain Res. Mol. Brain Res. 34 (1995) 209-220
37. Satoh M., and Minami M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68 (1995) 343-364
38. Scavini C., Rozza A., Bo P., Lanza E., Favalli L., Savoldi F., and Racagni G. κ-Opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits. Stroke 21 (1990) 943-947
39. Su D.S., Wang Z.H., Zheng Y.J., Zhao Y.H., and Wang X.R. Dose-dependent neuroprotection of delta opioid peptide [D-Ala2D-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats. Neurosci. Lett. 423 (2007) 113-117
40. Triantafilou M., Gamper F.G.J., Lepper P.M., Mouratis M.A., Schumann C., Harokopakis E., Schifferle R.E., Hajishengallis G., and Triantafilou K. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol. 9 (2007) 2030-2039
41. Tryoen-Toth P., Gravériaux-Ruff C., Maderspach K., and Labourdette G. Regulation of kappa-opioid receptor mRNA level by cyclic AMP and growth factors in cultured rat glial cells. Brain Res. Mol. Brain Res. 55 (1998) 141-150
42. Vila N., Castillo J., Dávalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
43. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu. Rev. Biochem. 73 (2004) 953-990
44. Xiong L.Z., Yang J., Wang Q., and Lu Z.H. Involvement of delta- and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats. Chin. Med. J. (Engl.) 120 (2007) 394-399
45. Yang D.Y., Pan H.C., Yen Y.J., Wang C.C., Chuang Y.H., Chen S.Y., Lin S.Y., Liao S.L., Raung S.L., Wu C.W., Chou M.C., Chiang A.N., and Chen C.J. Detrimental effects of post-treatment with fatty acids on brain injury in ischemic rats. Neurotoxicology 28 (2007) 1220-1229
46. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13496-13500
47. Zabramski J.M., Spetzler R.F., Selman R.S., Roessmann U.R., Hershey L.A., Crumrine R.C., and Macko R. Naloxone therapy during focal cerebral ischemia Evaluation in a primate model. Stroke 15 (1984) 621-629
48. Zeynalov E., Nemoto M., Hurn P.D., Koehler R.C., and Bhardwaj A. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide. J. Cereb. Blood Flow Metab. 26 (2006) 414-420
49. Zhang J., Haddad G.G., and Xia Y. δ-, but not μ- and κ-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885 (2000) 143-153
50. Zhao P., Huang Y., and Zuo Z. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J. Neuropathol. Exp. Neurol. 65 (2006) 945-952